352 related articles for article (PubMed ID: 28009981)
1. MARCKS protein overexpression in inflammatory breast cancer.
Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
[TBL] [Abstract][Full Text] [Related]
2. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.
Manai M; ELBini-Dhouib I; Finetti P; Bichiou H; Reduzzi C; Aissaoui D; Ben-Hamida N; Agavnian E; Srairi-Abid N; Lopez M; Amri F; Guizani-Tabbane L; Rahal K; Mrad K; Manai M; Birnbaum D; Mamessier E; Cristofanilli M; Boussen H; Kharrat M; Doghri R; Bertucci F
Cells; 2022 Sep; 11(18):. PubMed ID: 36139501
[TBL] [Abstract][Full Text] [Related]
3. MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
Manai M; Abdeljaoued S; Goucha A; Adouni O; Bettaieb I; Bouzaien H; Rahal K; Birnbaum D; Bertucci F; Gamoudi A
Cancer Biomark; 2019; 26(4):513-522. PubMed ID: 31771045
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
[TBL] [Abstract][Full Text] [Related]
5. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.
Debeb BG; Gong Y; Atkinson RL; Sneige N; Huo L; Gonzalez-Angulo AM; Hung MC; Valero V; Ueno NT; Woodward WA
J Exp Clin Cancer Res; 2014 Jul; 33(1):58. PubMed ID: 25051981
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract][Full Text] [Related]
7. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.
Doghri R; Manai M; Finetti P; Driss M; Agavnian E; Lopez M; Elghardallou M; Charafe-Jauffret E; Manai M; Chaffanet M; Birnbaum D; Mrad K; Bertucci F
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295532
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes in patients with inflammatory breast cancer; a single center experience.
Kertmen N; Babacan T; Keskin O; Solak M; Sarici F; Akin S; Arik Z; Aslan A; Ates O; Aksoy S; Ozisik Y; Altundag K
J BUON; 2015; 20(1):35-9. PubMed ID: 25778293
[TBL] [Abstract][Full Text] [Related]
9. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
Quan R; Ning Z; Wang Y; Yu W; Zhu H
Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
[TBL] [Abstract][Full Text] [Related]
11. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
[TBL] [Abstract][Full Text] [Related]
12. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Lacerda L; Reddy JP; Liu D; Larson R; Li L; Masuda H; Brewer T; Debeb BG; Xu W; Hortobágyi GN; Buchholz TA; Ueno NT; Woodward WA
Stem Cells Transl Med; 2014 Jul; 3(7):849-56. PubMed ID: 24833589
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
15. Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.
Chaher N; Arias-Pulido H; Terki N; Qualls C; Bouzid K; Verschraegen C; Wallace AM; Royce M
Breast Cancer Res Treat; 2012 Jan; 131(2):437-44. PubMed ID: 21360074
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.
Alexander A; Karakas C; Chen X; Carey JP; Yi M; Bondy M; Thompson P; Cheung KL; Ellis IO; Gong Y; Krishnamurthy S; Alvarez RH; Ueno NT; Hunt KK; Keyomarsi K
Oncotarget; 2017 Feb; 8(9):14897-14911. PubMed ID: 28107181
[TBL] [Abstract][Full Text] [Related]
19. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
20. Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non- Inflammatory Breast Cancer.
Hamdi K; Blancato J; Goerlitz D; Islam M; Neili B; Abidi A; Gat A; Ayed FB; Chivi S; Loffredo C; Jillson I; Elgaaied AB; Marrakchi R
Asian Pac J Cancer Prev; 2016; 17(4):1801-10. PubMed ID: 27221856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]